MADIGAN HEALTHCARE SYSTEM - December 2012
In a study conducted by Madigan Healthcare System, users of QueaseEASE® showed a statistically significant decrease in nausea, as well as a significantly higher perception of treatment effectiveness.
ST. JUDE CHILDREN’S RESEARCH HOSPITAL - September 2014
At St. Jude Children’s Research Hospital, data collected from a three-month pilot project showed QueaseEASE® to be a feasible intervention. It also found that patients, families and nursing staff were highly satisfied with QueaseEASE®.
FLOYD MEMORIAL HOSPITAL - August 2013
A Floyd Memorial Hospital study showed using QueaseEASE® for post-discharge nausea reduced nausea 100% of the time. In addition, nearly half experienced complete relief.
OREGON HEALTH AND SCIENCE UNIVERSITY - April 2017
Oregon Health and Science University conducted a limited size clinical trial of QueaseEASE® to test efficacy and patient satisfaction. Findings showed 85% of users had total relief of nausea and were satisfied with QueaseEASE®
BON SECOUR ST. FRANCIS HEALTH SYSTEM - March 2013
Clinical trials conducted at Bon Secour St. Francis Health System concluded that 70% of patients reported relief of nausea after using QueaseEASE®, both in the hospital and post-discharge.
SCRIPPS - March 2013
Scripps Clinic Carmel Valley conducted a small investigational trial that found that 62% of patients got relief from their nausea after inhaling QueaseEASE®. The average patient rating of the product was 4.5 out of 5.
STEPHENS MEMORIAL HOSPITAL - January 2014
A study conducted at Stephens Memorial Hospital showed that 90% of patients using QueaseEASE® experienced some relief from their nausea, with 50% experiencing complete relief.
UNIVERSITY OF COLORADO - April 2015
In a University of Colorado, descriptive qualitative study comparing QueaseEASE® to alcohol pads, patients and nurses both reported significantly higher satisfaction with QueaseEASE®.
HOUSTON METHODIST - May 2016
In a study conducted at Houston Methodist Sugar Land Hospital, results showed a 60% reduction in antiemetic drug use after patients inhaled QueaseEASE® in the PACU. This led to a 100% recommendation to include QueaseEASE® in their multi-modal therapy for PONV.
QUEENS MEDICAL CENTER - July 2012
A Queens Medical Center trial found a 15-minute decrease in PACU stay when nauseated patients used QueaseEASE®. There was also a 37% decrease in Phenergan use and more than a 50% decrease of Kytril administration. In addition, 82% of patients felt that QueaseEASE® helped relieve their nausea.
DEACONESS HOSPITAL - March 2017
In a prospective randomized study comparing QueaseEASE® to standard post-discharge nausea care, 100% of the patients using QueaseEASE® found effective relief from their PDN.
LOWELL GENERAL HOSPITAL - October 2018
In a randomized study comparing QueaseEASE® to conventional medication, PONV relief was achieved within 7.8 minutes for QueaseEASE® users, compared to 66.8 minutes for patients given antiemetics.
ALTA BASE SUMMIT MEDICAL CENTER - March 2016
An evaluative trial revealed that QueaseEASE® relieved PONV in 70% of PACU patients.
MISSION HOSPITAL OF PROVIDENCE ST JOSEPH HEALTH March 2017
A small trial conducted in the PACU found that 15 out of 52 patients did not require additional antiemetics after receiving QueaseEASE®, resulting in a cost savings of $750.
DOERNBECHER CHILDREN’S HOSPITAL - September 2017
A study conducted in a Level 1 Trauma Center Pediatric Emergency Department showed that 79% of patients’ nausea was reduced or eliminated after using QueaseEASE®
PROVIDENCE ST. PATRICK HOSPITAL - Awaiting Publication
In an investigational trial involving 65 patients at Providence St. Patrick Hospital, the need for additional antiemetics decreased by 71.8% when QueaseEASE was used as a first-line nausea treatment in PACU.
